Perrigo Company plc
NYSE:PRGODrug Manufacturers - Specialty & Generic
-$0.20 today
- Market cap
- $2.35B
- Beta
- 0.52
- P/E (TTM)
- -0.8
- EPS (TTM)
- -$13.10
- Dividend yield
- 11.65%
Volume 2.57M
Average 2.96M
PRGO Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Perrigo Company plcNYSE: PRGO
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents falls 12.0% from a year ago
Cash & equivalents stood at $399.7M at the end of Q2 FY2026, down 12.0% from a year earlier and up 11.9% from the prior quarter. Over 3 fiscal years it compounded at -4.0% a year.
Context
- Cash & equivalents amounted to 5.3% of total assets at the end of Q2 FY2026, up 0.8 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -12.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 531.6M USD
- Year-over-year change
- -4.9%
- 4-year CAGR
- -26.9%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 531.6M | -4.9% |
| FY2024 | 2024-12-31 | 558.8M | -25.6% |
| FY2023 | 2023-12-31 | 751.3M | +25.1% |
| FY2022 | 2022-12-31 | 600.7M | -67.8% |
| FY2021 | 2021-12-31 | 1.86B | — |
Cash & Equivalents vs competitors
How PRGO compares with its peers on the latest reported figures
- PRGO's Jun 2026 cash & equivalents of $399.7M is the 3rd highest of the 10 companies compared; the peer median is $179.95M.
- Its year-over-year change of -12.0% is the 7th highest of 10, against a peer median of +5.7%.
- Cash & equivalents amounts to 5.3% of total assets for PRGO, versus a peer median of 12.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.83B | +5.7% | +32.9% | 7.4% | |
| Sep 2026 | $563.5M | -12.8% | +43.7% | 20.8% | |
| Jun 2026 | $399.7M | -12.0% | -4.0% | 5.3% | |
| Sep 2026 | $366.27M | +27.7% | +46.3% | 82.1% | |
| Sep 2026 | $354.5M | +74.3% | -5.3% | 5.0% | |
| Jun 2026 | $179.95M | +24.4% | +11.3% | 12.6% | |
| Mar 2026 | $139.91M | -8.7% | +23.8% | 17.5% | |
| Sep 2026 | $136.53M | +21.1% | +36.8% | 27.0% | |
| Dec 2025 | $71.33M | -53.7% | -38.9% | 4.1% | |
HTFLHeartflow, Inc. Common Stock | Sep 2026 | $31.65M | -89.1% | — | 8.9% |
| Peer median (excluding PRGO) | $179.95M | +5.7% | +28.3% | 12.6% | |
Competitors are the stored peer set for PRGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.86B | 600.7M | 751.3M | 558.8M | 531.6M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 652.9M | 697.1M | 739.6M | 642.3M | 612.8M |
| Inventory | 1.02B | 1.15B | 1.14B | 1.08B | 1.15B |
| Other Current Assets | 16.1M | 271.8M | 201.1M | 199M | 504M |
| Total Current Assets | 3.86B | 2.72B | 2.83B | 2.48B | 2.8B |
| Property, Plant & Equipment (Net) | 1.03B | 1.14B | 1.1B | 1.09B | 1.07B |
| Goodwill | 3B | 3.49B | 3.53B | 3.32B | 2.05B |
| Intangible Assets | 2.15B | 3.29B | 2.99B | 2.43B | 2.35B |
| Long-term Investments | 0 | 0 | 0 | 0 | 25.4M |
| Tax Assets | 6.5M | 7.1M | 25.8M | 5.1M | 3.3M |
| Other Non-current Assets | 377.5M | 367.7M | 335.2M | 318.6M | 236.4M |
| Total Non-current Assets | 6.57B | 8.3B | 7.98B | 7.17B | 5.74B |
| Total Assets | 10.43B | 11.02B | 10.81B | 9.65B | 8.54B |
| Account Payables | 411.2M | 537.3M | 477.7M | 495.2M | 474.5M |
| Short-term Debt | 603.8M | 36.2M | 440.6M | 36.4M | 62.3M |
| Tax Payables | 16.5M | 14.4M | 42.1M | 17.4M | 20.8M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 49.1M | (28.4M) | 0 | 0 | 343.1M |
| Total Current Liabilities | 1.59B | 1.11B | 1.59B | 1.04B | 1.01B |
| Long-term Debt | 2.92B | 4.07B | 3.63B | 3.58B | 3.74B |
| Deferred Tax Liabilities | 239.3M | 368.2M | 262.3M | 203.2M | 168.9M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 382.8M | 433.5M | 559.8M | 499.2M | 511.3M |
| Total Non-current Liabilities | 3.69B | 5.06B | 4.45B | 4.28B | 4.59B |
| Total Liabilities | 5.27B | 6.18B | 6.04B | 5.33B | 5.6B |
| Common Stock | 7.04B | 6.94B | 6.84B | 6.73B | 6.61B |
| Retained Earnings | (1.93B) | (2.07B) | (2.08B) | (2.25B) | (3.68B) |
| Accumulated OCI | 35.5M | (27M) | 10.7M | (162.4M) | 14.1M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | (9.3M) |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 5.15B | 4.84B | 4.77B | 4.32B | 2.94B |
| Total Debt | 3.69B | 4.32B | 4.07B | 3.62B | 3.97B |
| Net Debt | 1.83B | 3.72B | 3.32B | 3.06B | 3.44B |
Perrigo Company plc
NYSE:PRGO
Intrinsic Alpha fair value
Locked
Current Price
$16.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.